Journal of breast cancer research最新文献

筛选
英文 中文
Sentinel lymph node biopsy in early breast cancer: A brief review 早期乳腺癌前哨淋巴结活检:简要回顾
Journal of breast cancer research Pub Date : 2023-05-06 DOI: 10.46439/breastcancer.2.014
S. Kadam, Tejaswini Kadam
{"title":"Sentinel lymph node biopsy in early breast cancer: A brief review","authors":"S. Kadam, Tejaswini Kadam","doi":"10.46439/breastcancer.2.014","DOIUrl":"https://doi.org/10.46439/breastcancer.2.014","url":null,"abstract":"","PeriodicalId":73629,"journal":{"name":"Journal of breast cancer research","volume":"31 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-05-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"79198482","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Weaknesses with research models and disparities: how PDX models strengthen both 研究模型的弱点和差异:PDX模型如何强化两者
Journal of breast cancer research Pub Date : 2022-09-24 DOI: 10.46439/breastcancer.1.009
{"title":"Weaknesses with research models and disparities: how PDX models strengthen both","authors":"","doi":"10.46439/breastcancer.1.009","DOIUrl":"https://doi.org/10.46439/breastcancer.1.009","url":null,"abstract":"","PeriodicalId":73629,"journal":{"name":"Journal of breast cancer research","volume":"124 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-09-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"89658080","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Analysis of treatment and outcomes in patients with locally advanced breast cancer 局部晚期乳腺癌患者的治疗及预后分析
Journal of breast cancer research Pub Date : 2022-09-24 DOI: 10.46439/breastcancer.1.008
{"title":"Analysis of treatment and outcomes in patients with locally advanced breast cancer","authors":"","doi":"10.46439/breastcancer.1.008","DOIUrl":"https://doi.org/10.46439/breastcancer.1.008","url":null,"abstract":"","PeriodicalId":73629,"journal":{"name":"Journal of breast cancer research","volume":"1 1 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-09-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"78656142","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
How to inhibit breast cancer and breast cancer metastasis with Akt inhibitors: Lessons learned from studies in mice Akt抑制剂如何抑制乳腺癌和乳腺癌转移:从小鼠研究中获得的经验教训
Journal of breast cancer research Pub Date : 2022-04-10 DOI: 10.46439/breastcancer.1.007
N. Hay
{"title":"How to inhibit breast cancer and breast cancer metastasis with Akt inhibitors: Lessons learned from studies in mice","authors":"N. Hay","doi":"10.46439/breastcancer.1.007","DOIUrl":"https://doi.org/10.46439/breastcancer.1.007","url":null,"abstract":"The PI3K/Akt signaling pathway is frequently hyperactivated in different types of breast cancer. In the past two decades, major efforts have been made to develop inhibitors of this pathway to treat cancer patients. However, the most evolutionarily conserved function of this pathway is in cellular and organismal metabolism, which is hijacked by cancer cells. Thus, adverse metabolic consequences are expected when PI3K or Akt is targeted. These metabolic consequences, particularly hyperinsulinemia, could impede the efficacy of treatment. This review summarizes recent genetic studies in mice that could pave the way to efficient breast cancer and breast cancer metastasis treatment with Akt inhibitors.","PeriodicalId":73629,"journal":{"name":"Journal of breast cancer research","volume":"20 1","pages":"30 - 33"},"PeriodicalIF":0.0,"publicationDate":"2022-04-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"90438759","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Kindlins as modulators of breast cancer progression Kindlins作为乳腺癌进展的调节剂
Journal of breast cancer research Pub Date : 2022-02-03 DOI: 10.46439/breastcancer.1.006
E. Plow, E. Pluskota, K. Białkowska
{"title":"Kindlins as modulators of breast cancer progression","authors":"E. Plow, E. Pluskota, K. Białkowska","doi":"10.46439/breastcancer.1.006","DOIUrl":"https://doi.org/10.46439/breastcancer.1.006","url":null,"abstract":"Kindlin-1 (K1, FERMT1), Kindlin-2 (K2, FERMT2), and Kindlin-3 (K3, FERMT3) are the three members of the kindlin family of adapter proteins found in mammals. One or more kindlins are found in most cell types, K1 primarily in epithelial cells, K3 in primarily hematopoietic cells and also endothelial cells, and K2 is very broadly distributed. The kindlins consist primarily of a 4.1-erzin-radixin-moiesin (FERM) domain, which is transected by a lipid-binding plextrin-homology (PH) domain. Deficiencies of each kindlin in mice and/ or humans have profound pathogenic consequences. The most well-established function of kindlins depends on their ability to participate in the activat integrin adhesion receptors. This function depends on the binding of each kindlin to the beta subunit of integrins where it cooperates with talin to enhance avidity of interactions with cognate extracellular matrix ligands. Deficiencies of many different integrins are lethal, are critical for normal development of mammary tissue, and excessive expression and/or activation of certain integrins are associated with progression and metastasis of breast cancer. However, via its interaction with many other intracellular proteins, kindlins can influence numerous cellular responses. Changes in expression of each of the three kindlins have been reported in association with breast cancer, with several studies indicating that kindlins are among the most upregulated genes in breast cancer. The association of abnormal functions of K2 with breast cancer is particularly extensive with many reports indicating that it is a major driver of breast cancer via its promotion of cancer cell proliferation, survival, adhesion, migration, invasion, the epithelial-to-mesenchymal transition and its influence on macrophage recruitment and phenotype. These associations suggest that the kindlins and their functions represent an intriguing therapeutic target for exploration of breast cancer therapy.","PeriodicalId":73629,"journal":{"name":"Journal of breast cancer research","volume":"85 1","pages":"20 - 29"},"PeriodicalIF":0.0,"publicationDate":"2022-02-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"78142754","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Breast cancer: an up-date review 乳腺癌:最新综述
Journal of breast cancer research Pub Date : 2021-07-15 DOI: 10.46439/breastcancer.1.002
{"title":"Breast cancer: an up-date review","authors":"","doi":"10.46439/breastcancer.1.002","DOIUrl":"https://doi.org/10.46439/breastcancer.1.002","url":null,"abstract":"","PeriodicalId":73629,"journal":{"name":"Journal of breast cancer research","volume":"27 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2021-07-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"87272867","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
EZH2 and cancer progression: An intricate relation that continues to grow EZH2与癌症进展:一种持续增长的复杂关系
Journal of breast cancer research Pub Date : 2021-07-15 DOI: 10.46439/breastcancer.1.003
{"title":"EZH2 and cancer progression: An intricate relation that continues to grow","authors":"","doi":"10.46439/breastcancer.1.003","DOIUrl":"https://doi.org/10.46439/breastcancer.1.003","url":null,"abstract":"","PeriodicalId":73629,"journal":{"name":"Journal of breast cancer research","volume":"31 3","pages":""},"PeriodicalIF":0.0,"publicationDate":"2021-07-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"72474525","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Commentary on: The actual benefit of intraoperative radiation therapy using 50 kV x-rays in early breast cancer: A retrospective study of 676 patients 评论:早期乳腺癌术中50kv x射线放射治疗的实际益处:一项676例患者的回顾性研究
Journal of breast cancer research Pub Date : 2021-07-15 DOI: 10.46439/breastcancer.1.004
{"title":"Commentary on: The actual benefit of intraoperative radiation therapy using 50 kV x-rays in early breast cancer: A retrospective study of 676 patients","authors":"","doi":"10.46439/breastcancer.1.004","DOIUrl":"https://doi.org/10.46439/breastcancer.1.004","url":null,"abstract":"","PeriodicalId":73629,"journal":{"name":"Journal of breast cancer research","volume":"323 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2021-07-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"78406909","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Progress and perspectives of organoid cultures of primary human breast cancer 原发性人乳腺癌类器官培养研究进展及展望
Journal of breast cancer research Pub Date : 2021-07-15 DOI: 10.46439/breastcancer.1.005
{"title":"Progress and perspectives of organoid cultures of primary human breast cancer","authors":"","doi":"10.46439/breastcancer.1.005","DOIUrl":"https://doi.org/10.46439/breastcancer.1.005","url":null,"abstract":"","PeriodicalId":73629,"journal":{"name":"Journal of breast cancer research","volume":"2 1 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2021-07-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"79712323","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Kindlins as modulators of breast cancer progression. 作为乳腺癌进展调节剂的 Kindlins。
Journal of breast cancer research Pub Date : 2021-01-01
Edward F Plow, Elzbieta Pluskota, Katarzyna Bialkowska
{"title":"Kindlins as modulators of breast cancer progression.","authors":"Edward F Plow, Elzbieta Pluskota, Katarzyna Bialkowska","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Kindlin-1 (K1, FERMT1), Kindlin-2 (K2, FERMT2), and Kindlin-3 (K3, FERMT3) are the three members of the kindlin family of adapter proteins found in mammals. One or more kindlins are found in most cell types, K1 primarily in epithelial cells, K3 in primarily hematopoietic cells and also endothelial cells, and K2 is very broadly distributed. The kindlins consist primarily of a 4.1-erzin-radixin-moiesin (FERM) domain, which is transected by a lipid-binding plextrin-homology (PH) domain. Deficiencies of each kindlin in mice and/ or humans have profound pathogenic consequences. The most well-established function of kindlins depends on their ability to participate in the activat integrin adhesion receptors. This function depends on the binding of each kindlin to the beta subunit of integrins where it cooperates with talin to enhance avidity of interactions with cognate extracellular matrix ligands. Deficiencies of many different integrins are lethal, are critical for normal development of mammary tissue, and excessive expression and/or activation of certain integrins are associated with progression and metastasis of breast cancer. However, via its interaction with many other intracellular proteins, kindlins can influence numerous cellular responses. Changes in expression of each of the three kindlins have been reported in association with breast cancer, with several studies indicating that kindlins are among the most upregulated genes in breast cancer. The association of abnormal functions of K2 with breast cancer is particularly extensive with many reports indicating that it is a major driver of breast cancer via its promotion of cancer cell proliferation, survival, adhesion, migration, invasion, the epithelial-to-mesenchymal transition and its influence on macrophage recruitment and phenotype. These associations suggest that the kindlins and their functions represent an intriguing therapeutic target for exploration of breast cancer therapy.</p>","PeriodicalId":73629,"journal":{"name":"Journal of breast cancer research","volume":"1 2","pages":"20-29"},"PeriodicalIF":0.0,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9352049/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9816361","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书